These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2884813)

  • 1. Hemodynamic effects of loud noise before and after central sympathetic nervous stimulation.
    Eggertsen R; Svensson A; Magnusson M; Andrén L
    Acta Med Scand; 1987; 221(2):159-64. PubMed ID: 2884813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and cardiac haemodynamic interactions between guanfacine and hydrallazine in hypertensive patients.
    Velasco M; Urbina-Quintana A; Morillo J; Vizcarrondo H; Ramirez A; Hernández E; Hernández-Pieretti O
    Eur J Clin Pharmacol; 1984; 27(4):393-6. PubMed ID: 6394347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antihypertensive effect of guanfacine compared with methyldopa.
    van der Merwe CJ; Kruger SA
    S Afr Med J; 1980 Mar; 57(11):400-4. PubMed ID: 6105713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
    Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of guanfacine on ambulatory blood pressure and its variability in elderly patients with essential hypertension.
    Dupont AG; Vanderniepen P; Six RO
    Br J Clin Pharmacol; 1987 Apr; 23(4):397-401. PubMed ID: 3555578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
    Erina EV; Beliakova EV; Charyev KhZ; Panfilov VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):63-7. PubMed ID: 2663029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clonidine and guanfacine in essential hypertension.
    Farsang C; Varga K; Vajda L; Alföldi S; Kapocsi J
    Clin Pharmacol Ther; 1984 Nov; 36(5):588-94. PubMed ID: 6386275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanfacine as monotherapy for systemic hypertension.
    Fillingim JM; Blackshear JL; Strauss A; Strauss M
    Am J Cardiol; 1986 Mar; 57(9):50E-54E. PubMed ID: 3513531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of low dose guanfacine, once a day, for 24-hour control of essential hypertension.
    Keenan RE; Black PL; Freudenburg JC; Hill JA; Holmburg CE; Reitbrock MJ; Sullivan MJ; Thompson MT; Wright DL
    Am J Cardiol; 1986 Mar; 57(9):38E-42E. PubMed ID: 3513529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and endocrine responses to guanfacine in normotensive volunteers and hypertensive patients.
    Rosenthal JH
    Am J Cardiol; 1986 Mar; 57(9):22E-26E. PubMed ID: 3513526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension.
    Materson BJ; Kessler WB; Alderman MH; Canosa FL; Finnerty FA; Savran SV; McMillen JI; Marlon AM
    Am J Cardiol; 1986 Mar; 57(9):32E-37E. PubMed ID: 3513528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-dependent blood pressure effects of guanfacine.
    Frisk-Holmberg M; Wibell L
    Clin Pharmacol Ther; 1986 Feb; 39(2):169-72. PubMed ID: 2867846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guanfacine in the treatment of arterial hypertension. Apropos of 471 cases in a hospital milieu].
    Carette B
    Ann Cardiol Angeiol (Paris); 1984; 33(2):123-6. PubMed ID: 6143529
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamics in hypertensive patients before and during guanfacine treatment.
    Schäfer N; Rauh J; Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new antihypertensive agent used in a clinical setting].
    Wetzels E; Raschig A; Kaiser HJ
    Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
    Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
    Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
    Rosenthal J; Schäfer N; Rauh J; Raschig A
    Dtsch Med Wochenschr; 1980 Nov; 105(48):1680-4. PubMed ID: 7002524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.